文献速递免疫规划卫生政策与健康促进

法国65岁及以上人群带状疱疹疫苗可接受性与认知的观察性研究

Acceptability and perception of the herpes zoster vaccine in the 65 and over population: A French observational study.
PubMed 文献 · Vaccine · 2020-07-21

该研究在法国里昂对65岁及以上门诊和住院患者进行面对面问卷调查,共访谈907人,平均年龄75.8岁。结果显示87.6%了解带状疱疹,68.9%在有危险因素时愿意接种疫苗,但公众对疫苗的认知仍不足。

要点

  • 65岁及以上人群中87.6%了解带状疱疹疾病。
  • 68.9%的受访者在有危险因素时愿意接种带状疱疹疫苗。
  • 公众对带状疱疹疫苗的认知仍较缺乏。

核心结论

  • 65岁及以上人群对带状疱疹疾病认知较高,但疫苗认知不足,多数人在有危险因素时愿意接种。

研究设计与样本

  • 法国里昂的观察性研究,基于2018年1月至2019年3月面对面访谈问卷,共访谈907名65岁及以上门诊或住院患者,平均年龄75.8岁。

主要发现

  • 87.6%(795人)了解带状疱疹。
  • 68.9%(625人)在有危险因素时愿意接种带状疱疹疫苗。
  • 参与者了解带状疱疹疾病,但公众对疫苗的认知仍缺乏。

临床怎么用

  • 在65岁及以上人群的健康教育中应加强带状疱疹疫苗信息传播,尤其针对有危险因素者。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The aim of the study was to evaluate the acceptability and to describe the perception of vaccination against herpes zoster (HZ) for outpatients and hospitalized patients in Lyon, France, aged 65 years and over. An observational study was based on a questionnaire completed from a face-to-face interview from January 2018 to March 2019. Volunteer outpatients who attended private medical laboratories or who were hospitalized in the geriatric department, or who were at the ambulatory medical clinic for a consultation were asked to participate. A total of 907 individuals were interviewed, with a mean age of 75.8 years. A large majority 87.6% (795) knew about HZ and 68.9% (625) would agree to be vaccinated against HZ if they had risk factors. The participants had knowledge of HZ as a disease but vaccine awareness is still lacking among the general public.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Del Signore C, Hemmendinger A, Khanafer N, et al. Acceptability and perception of the herpes zoster vaccine in the 65 and over population: A French observational study. Vaccine. 2020. PMID: 32703748. doi:10.1016/j.vaccine.2020.07.004

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。